Blog

In 2019, independent tests indicated that there were unsafe levels of a cancer-causing carcinogen in Zantac and the generic forms of the medication, ranitidine. Major pharmacies all over the US began to take these medications off their shelves, and now the US Food and Drug Administration (FDA) has formally requested that manufacturers pull all of…

A common weight management drug has made recent headlines as researchers are linking the appetite-suppressant pill to an increased risk of cancer. Belviq, the brand name for generic lorcaserin, is a serotonin receptor agonist that is primarily used for weight loss, targeting chemicals in the brain to influence a person’s hunger and/or appetite. Manufactured by…